Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce A Cramer

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Clinical Therapeutics|December 13, 2006
The effect of dosing frequency on compliance and persistence with bisphosphonate therapy in postmenopausal women: a comparison of studies in the United States, the United Kingdom, and FranceJoyce A Cramer, Niall O Lynch, Anne-Francoise Gaudin, et al.
Epilepsy & Behavior : E&B|August 8, 2007
The impact of seizures and adverse effects on global health ratingsJoyce A Cramer, Nancy A Brandenburg, Xiao Xu, et al.
Epilepsy Research|December 4, 2003
Tolerability of levetiracetam in elderly patients with CNS disordersJoyce A Cramer, Ilo E Leppik, Katrien De Rue, et al.
Epilepsy & Behavior : E&B|April 17, 2003
A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trialsJoyce A Cramer, Katrien De Rue, Orrin Devinsky, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|January 7, 2004
Development of a growth hormone injection questionnaire for adolescentsJoyce A Cramer, Marie Claude Simeoni, Stéphane Robitail, et al.
Journal of Adolescence|July 19, 2005
Brief report: a quality of life instrument for adolescents with growth disordersJoyce A Cramer, Marie Claude Simeoni, Pascal Auquier, et al.
Behaviour Research and Therapy|March 5, 2004
Electronic monitoring and counseling to improve medication adherenceMarc I Rosen, Michael O Rigsby, Jamelah T Salahi, et al.
Epilepsy & Behavior : E&B|January 31, 2015
Health-care costs and utilization related to long- or short-acting antiepileptic monotherapy useJoyce A Cramer, Zhixiao J Wang, Eunice Chang, et al.
Epilepsia|February 27, 2007
Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizuresChristian Elger, Meir Bialer, Joyce A Cramer, et al.
Epilepsy & Behavior : E&B|August 18, 2020
Associations between seizure severity change and patient characteristics, changes in seizure frequency, and health-related quality of life in patients with focal seizures treated with adjunctive eslicarbazepine acetate: Post hoc analyses of clinical trial resultsJoyce A Cramer, Sam Colman, Kathryn P Anastassopoulos, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Clinical Therapeutics|December 13, 2006
The effect of dosing frequency on compliance and persistence with bisphosphonate therapy in postmenopausal women: a comparison of studies in the United States, the United Kingdom, and FranceJoyce A Cramer, Niall O Lynch, Anne-Francoise Gaudin, et al.
Epilepsy & Behavior : E&B|August 8, 2007
The impact of seizures and adverse effects on global health ratingsJoyce A Cramer, Nancy A Brandenburg, Xiao Xu, et al.
Epilepsy Research|December 4, 2003
Tolerability of levetiracetam in elderly patients with CNS disordersJoyce A Cramer, Ilo E Leppik, Katrien De Rue, et al.
Epilepsy & Behavior : E&B|April 17, 2003
A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trialsJoyce A Cramer, Katrien De Rue, Orrin Devinsky, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|January 7, 2004
Development of a growth hormone injection questionnaire for adolescentsJoyce A Cramer, Marie Claude Simeoni, Stéphane Robitail, et al.
Journal of Adolescence|July 19, 2005
Brief report: a quality of life instrument for adolescents with growth disordersJoyce A Cramer, Marie Claude Simeoni, Pascal Auquier, et al.
Behaviour Research and Therapy|March 5, 2004
Electronic monitoring and counseling to improve medication adherenceMarc I Rosen, Michael O Rigsby, Jamelah T Salahi, et al.
Epilepsy & Behavior : E&B|January 31, 2015
Health-care costs and utilization related to long- or short-acting antiepileptic monotherapy useJoyce A Cramer, Zhixiao J Wang, Eunice Chang, et al.
Epilepsia|February 27, 2007
Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizuresChristian Elger, Meir Bialer, Joyce A Cramer, et al.
Epilepsy & Behavior : E&B|August 18, 2020
Associations between seizure severity change and patient characteristics, changes in seizure frequency, and health-related quality of life in patients with focal seizures treated with adjunctive eslicarbazepine acetate: Post hoc analyses of clinical trial resultsJoyce A Cramer, Sam Colman, Kathryn P Anastassopoulos, et al.
Pageof 9